Delivery Order SPE2DB22D9101-SPE2DB25FU7MV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials on August 20, 2025. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 11, 2025, with performance taking place in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, will supply the yellow fever vaccine vials to support federal healthcare needs....
- The Defense Logistics Agency awarded a delivery order valued at $2,226.84 to DMS Pharmaceutical Group Inc. on August 19, 2025, for the provision of YF-VAX 1 dose vials, a yellow fever vaccine product. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, was issued without a set-aside designation. Performance will take place at DMS Pharmaceutical Group's facility in Park Ridge, Illinois. The contract represents a discrete fulfillment under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, a yellow fever vaccine product. The contract, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, operates under a firm fixed-price structure with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Illinois...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,226.84 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 Dose Vials. This delivery order, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, carries no set-aside designation. The award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $27,835.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 21, 2025, for the supply of YF-VAX 1 dose vials, with an ultimate completion date of August 11, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order falls under DMS's existing $499.999 billion Indefinite Delivery Contract with DLA through the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. on August 5, 2025, for the supply of YF-VAX 1 dose vials with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order does not utilize a set-aside designation and represents a straightforward pharmaceutical procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, with an ultimate completion date of August 28, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order employs firm fixed-price terms and represents a standard procurement action within the agency's pharmaceutical supply operations....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, a $499.9 billion contract vehicle valid through November 2026 that enables the agency to procure pharmaceutical products and medical supplies for...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,189.20 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,560,800 doses of the YF-VAX yellow fever vaccine to support the recurring medical supply needs of military health facilities. This delivery order is issued under DMS Pharmaceutical Group's indefinite delivery contract (IDC) with the DLA,...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $2,783.55 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 15, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the...
- SPE2DB22D9101Indefinite Delivery Contract
- SPE2DB22D9101-SPE2DB25FU7MVDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $2,226.84 to DMS Pharmaceutical Group Inc. for the supply of YF-VAX 1 dose vials. This delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, represents a purchase of yellow fever vaccine product to support federal healthcare requirements. The award carries no set-aside designation and will be performed in Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its headquarters. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a significant supplier within the federal pharmaceutical supply chain. The company operates under a substantial Indefinite Delivery Contract (IDC) with the DLA valued at $499.999 billion and valid through November 2026, which serves as the vehicle for this delivery order. This IDC encompasses a broad range of pharmaceutical products including vaccines, prescription medications, biologics, and medical consumables for military and federal healthcare facilities. As a consistent federal contractor since 2001, DMS Pharmaceutical Group leverages its woman-owned small business status to compete effectively in DLA pharmaceutical procurement and has established itself as a critical distributor supporting Department of Defense medical supply needs nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/8/25 |